September 06, 2018
Dietmar Siemssen to assume as Chief Executive Officer on November 1, 2018. Previously held position as Stabilus CEO. Speaker of the Management Board and CFO...
More July 11, 2018
With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug...
More April 25, 2018
Duesseldorf, April 25, 2018 – The distribution of a dividend of EUR 1.10 per share was approved at the Annual General Meeting of Gerresheimer AG held today in...
More April 12, 2018
Revenues at constant exchange rates EUR 299.2m in first quarter of 2018, as expected, stable relative to prior-year period; organic revenue growth 0.4% ...
More February 22, 2018
Fourth-quarter revenues up 4.7%, with organic growth of 6.7%. Slight 2.0% decrease for full year 2017 to EUR 1,348.3m. Revenues at constant exchange rates...
More February 05, 2018
Dr. Christian Fischer, Chairman of the Management Board of Gerresheimer AG, will leave the Company with immediate effect. Dr. Fischer has asked for an amicable...
More January 23, 2018
Düsseldorf, January 23, 2018 - On December 22, 2017, the US President signed the US tax reform, also known as the Tax Cuts and Jobs Act.
More January 08, 2018
Duesseldorf, January 8, 2018 – Dr. Lukas Burkhardt (38) has been appointed to the Management Board of Gerresheimer AG effective January 1, 2018. Lukas Burkhardt...
More October 11, 2017
Revenues down from EUR 350.4m in Q3 2016 to EUR 331.5m in Q3 2017; organic decrease of 4.3%. Adjusted EBITDA margin slightly improved to 23.4% (Q3 2016: 23.2%) ...
More 